Furthermore, CRISPR Therapeutics will share the profits generated from Casgevy with Vertex Pharmaceuticals, with which it developed the medicine; Vertex is entitled to 60% of the program profits.

These do not influence editorial content, though Vox Media may earn commissions for products purchased via affiliate links. You can find additional information about Polygon’s ethics policy here.

Players across platforms can progress through the tower bosses with their Pals, but know enabling crossplay can be a little confusing for players who haven’t messed with their world settings ...

I f you want to create highly detailed or organic 3D models, 3D sculpting is the best technique. Unlike other 3D design methods that rely on manipulating vertices, edges, and face ...

Intel hasn't been very good with processors lately. Perhaps they are focusing on creating video cards and competing with NVIDIA/AMD? Today we're going ...

DexCom has a significant (and expanding) growth runway in its market. Vertex Pharmaceuticals is an innovative biotech with a growing lineup and rich pipeline. Both stocks should deliver excellent ...

Michael McWhertor is a journalist with more than 17 years of experience covering video games, technology, movies, TV, and entertainment. The Lego Group and The Pokémon Company are teaming up for ...

Maddy Myers has run Polygon’s games section since 2020 as deputy editor. She has worked in games journalism since 2007, at Kotaku, The Mary Sue, and the Boston Phoenix. It’s a strange time to ...

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...

The lawsuit, which Polygon has reviewed, was filed in January in Louisiana state court before NetEase filed for the case to be moved to federal court in March. In a letter sent to NetEase CEO Ding ...